Literature DB >> 10888070

Regional brain metabolism during alcohol intoxication.

G J Wang1, N D Volkow, D Franceschi, J S Fowler, P K Thanos, N Scherbaum, N Pappas, C T Wong, R J Hitzemann, C A Felder.   

Abstract

BACKGROUND: Ethanol has a broad range of actions on many neurotransmitter systems. The depressant actions of ethanol in the brain are related in part to facilitation of gamma-aminobutyric acid (GABA) neurotransmission via its interaction with the benzodiazepine/GABA receptor complex. The purpose of this study was to evaluate the effects of ethanol on regional brain metabolism in 10 healthy right-handed men. The results were compared with those we previously published in a different group of 16 normal male subjects who received intravenous lorazepam, a benzodiazepine drug that also enhances GABA neurotransmission.
METHODS: The subjects were scanned with positron emission tomography and [F-18] fluorodeoxyglucose twice: 40 min after the end of placebo (diet soda) or ethanol (0.75 g/kg) oral administration. Image data sets were analyzed by using both the region of interest and the statistical parametric mapping (SPM) approach. SPM was used to generate a difference image between baseline and ethanol, which we compared to the difference image between baseline and lorazepam (30 microg/kg).
RESULTS: Ethanol significantly increased self-reports of "high" (p < or = 0.0001), dizziness (p < or = 0.004), and intoxication (p < or = 0.0001). Ethanol significantly decreased whole brain (-25 +/- 6%, p < or = 0.0001) and regional metabolism. Normalization of the regional measures by whole brain metabolism (relative measures) showed that ethanol decreased relative metabolic activity in occipital cortex (-4.9 +/- 4.1%, p < or = 0.006), whereas it increased relative metabolic act in left temporal cortex (+3.5 +/- 2.9%, p < or = 0.006) and left basal ganglia (+9 +/- 6.3%, p < or = 0.0009). SPM analyses revealed the same pattern of responses as the relative measures, showing decreases in occipital cortex and increases in left temporal cortex. Comparison of the relative measures and the SPM analyses obtained with lorazepam data revealed a similar pattern of effects, with relative decreases in occipital cortex (-7.8 +/- 4.8%) and relative increases in left temporal cortex (+3.8 +/- 5.7%). Lorazepam, but not ethanol, also decreased thalamic metabolism (-11.2 +/- 7.2%).
CONCLUSIONS: These results support similar though not identical mechanisms for the effects of alcohol and benzodiazepines on brain glucose metabolism. The fact that lorazepam, but not alcohol, reduced thalamic metabolism, an effect associated with sleepiness, could explain the higher sedative effects of lorazepam than of alcohol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888070

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  35 in total

1.  Fetal brain during a binge drinking episode: a dynamic susceptibility contrast MRI fetal brain perfusion study.

Authors:  Peter Kochunov; Carlos Castro; Duff M Davis; Donald Dudley; Hsiao-Ying Wey; David Purdy; Peter T Fox; Calvin Simerly; Gerald Schatten
Journal:  Neuroreport       Date:  2010-07-14       Impact factor: 1.837

2.  Moderate doses of alcohol disrupt the functional organization of the human brain.

Authors:  Nora D Volkow; Yeming Ma; Wei Zhu; Joanna S Fowler; Juan Li; Manlong Rao; Klaus Mueller; Kith Pradhan; Christopher Wong; Gene-Jack Wang
Journal:  Psychiatry Res       Date:  2008-02-15       Impact factor: 3.222

3.  Acute ethanol effects on brain activation in low- and high-level responders to alcohol.

Authors:  Ryan S Trim; Alan N Simmons; Neil J Tolentino; Shana A Hall; Scott C Matthews; Shannon K Robinson; Tom L Smith; Claudia B Padula; Martin P Paulus; Susan F Tapert; Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2010-05-07       Impact factor: 3.455

4.  Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.

Authors:  Dardo G Tomasi; Corinde E Wiers; Ehsan Shokri-Kojori; Amna Zehra; Veronica Ramirez; Clara Freeman; Jamie Burns; Christopher Kure Liu; Peter Manza; Sung W Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Int J Neuropsychopharmacol       Date:  2019-09-01       Impact factor: 5.176

5.  Effects of morphine and alcohol on functional brain connectivity during "resting state": a placebo-controlled crossover study in healthy young men.

Authors:  Najmeh Khalili-Mahani; Remco M W Zoethout; Christian F Beckmann; Evelinda Baerends; Marieke L de Kam; Roelof P Soeter; Albert Dahan; Mark A van Buchem; Joop M A van Gerven; Serge A R B Rombouts
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

6.  Spatial heterogeneity of the relation between resting-state connectivity and blood flow: an important consideration for pharmacological studies.

Authors:  Najmeh Khalili-Mahani; Matthias J van Osch; Mark de Rooij; Christian F Beckmann; Mark A van Buchem; Albert Dahan; Johannes M van Gerven; Serge A R B Rombouts
Journal:  Hum Brain Mapp       Date:  2012-12-26       Impact factor: 5.038

7.  Alcohol attenuates load-related activation during a working memory task: relation to level of response to alcohol.

Authors:  Martin P Paulus; Susan F Tapert; Carmen Pulido; Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2006-08       Impact factor: 3.455

Review 8.  Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Authors:  Valentina Berti; Lisa Mosconi; Alberto Pupi
Journal:  PET Clin       Date:  2014-04

9.  Alcohol impairs auditory processing of frequency changes and novel sounds: a combined MEG and EEG study.

Authors:  Seppo Kähkönen; Essi Marttinen Rossi; Hidehisa Yamashita
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

10.  Gender differences in alcohol impairment of simulated driving performance and driving-related skills.

Authors:  Melissa A Miller; Jessica Weafer; Mark T Fillmore
Journal:  Alcohol Alcohol       Date:  2009-09-28       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.